Microbot Medical Inc. — Director's Dealing 2019

Jan 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2019-01-21

Reporting Person: Burell Scott R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-21	Stock Option (Right to Buy)	$8.60	A	2326	Acquired	2029-01-21	Common Stock, par value $0.01 per share (2326)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.